BAX Baxter International Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
BAX Stock | Fundamental Analysis & Investment Insights
NYSE
Healthcare
Medical Instruments & Supplies
Current Price
Live
$19.84
Analyst Target
$23.13
+16.6%
Upside
52W High
$37.74
52W Low
$17.4
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
78%
Analysis Accuracy
BAX exhibits a weak fundamental profile with a Piotroski F-Score of just 2/9, indicating significant financial distress risks. Despite a reasonable forward P/E of 8.75 and modest revenue growth, the company is unprofitable (negative net margin and ROE), carries a high debt/equity ratio of 1.35, and has a dangerously elevated payout ratio of over 300%, threatening dividend sustainability. The stock's technical trend is bearish, price has declined over 70% in five years, and insider sentiment is neutral with no recent buying activity. While the current price of $19.84 appears low relative to analyst target of $23.13, the lack of profitability and deteriorating earnings cast serious doubts on valuation support.
Key Strengths
Revenue growth of 5.0% YoY shows top-line resilience in a challenging environment
Operating margin of 10.12% and gross margin of 37.93% remain healthy relative to sector averages
Current ratio of 1.84 indicates adequate short-term liquidity
Forward P/E of 8.75 is significantly below sector average, suggesting potential value appeal
Dividend yield of 2.59% provides some income incentive despite sustainability concerns
Key Risks
Piotroski F-Score of 2/9 signals severe financial weakness and high risk of continued underperformance
Negative profit margin (-3.09%) and ROE (-4.66%) indicate core unprofitability
Payout ratio of 307.69% is unsustainable and raises high risk of dividend cut
Technical trend score of 0/100 reflects strong downward price momentum
Long-term price performance is deeply negative: -72.4% over 5 years
AI Fair Value Estimate
Based on comprehensive analysis
$18.5
-6.8% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BAX against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BAX from our newsroom.
Newest → oldest
No matching news yet.